脑源性神经营养因子对经颅磁刺激治疗难治性抑郁症的疗效预测作用

doi:10.3969/j.issn.1006-7795.2022.02.011

首都医科大学学报 ›› 2022, Vol. 43 ›› Issue (2): 227-232.doi: 10.3969/j.issn.1006-7795.2022.02.011

• 精神疾病神经调控和康复技术研究 • 上一篇下一篇

脑源性神经营养因子对经颅磁刺激治疗难治性抑郁症的疗效预测作用

孙丛丛^1,2, 吴涵^1,2, 周丹娜^1,2, 姜玮^1,2, 王雯^1,2, 杨春林^1,2, 马辛^1,2, 任艳萍^1,2*

1.首都医科大学附属北京安定医院精神科精神疾病诊断与治疗北京市重点实验室&国家精神心理疾病临床医学研究中心,北京 100088;
2.首都医科大学人脑保护高精尖创新中心,北京 100069

收稿日期:2021-11-10 出版日期:2022-04-21 发布日期:2022-04-14
基金资助:
国家重点研发计划(2017YFC131110),北京市科学技术委员会科技重大专项(D171100007017001)。

Brain derived neurotrophic factor as the predictor of efficacy for repetitive transcranial magnetic stimulation in the treatment of refractory depression

Sun Congcong^1,2, Wu Han^1,2, Zhou Danna^1,2, Jiang Wei^1,2, Wang Wen^1,2, Yang Chunlin^1,2, Ma Xin^1,2, Ren Yanping^1,2*

1. Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing Key Laboratory of Mental Disorders & The National Clinical Research Center for Mental Disorders, Beijing 100088, China;
2. Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069, China

Received:2021-11-10 Online:2022-04-21 Published:2022-04-14
Contact: *E-mail:renyanping@ccmu.edu.cn
Supported by:
National Key Research & Development Program of China (2017YFC131110), Beijing Municipal Science & Technology Commission (D171100007017001).

摘要/Abstract

摘要： 目的探讨脑源性神经营养因子(brain derived neurotrophic factor, BDNF)对重复经颅磁刺激 (repetitive transcranial magnetic stimulation, rTMS)治疗难治性抑郁症疗效的预测作用。方法将59例难治性抑郁症患者分为治疗组和对照组,其中治疗组34例,对照组25例。治疗组接受2周的高频(10 Hz)rTMS治疗,对照组接受2周伪刺激治疗。采用汉密尔顿抑郁量表-17项(Hamilton Depression Scale-17 Item, HAMD-17)、汉密尔顿焦虑量表(Hamilton Anxiety Scale,HAMA)评估临床症状;采用酶联免疫法测定血清BDNF浓度。评估时间点为基线、治疗(2周)末、随访(6周)末。结果治疗组和对照组HAMD-17评分和HAMA评分均随治疗时间延长而逐渐降低(P_时间<0.05),组间比较差异无统计学意义(P_组间>0.05);治疗2周后,治疗组有效率(70.59%)高于对照组有效率(44%),差异有统计学意义(P=0.04)。治疗后,治疗组BDNF降低程度与对照组比较差异有统计学意义(P_组间<0.05)。基线BDNF浓度与疗效呈正相关(P<0.05)。治疗中无严重不良事件发生。结论 rTMS治疗难治性抑郁症有效;血清BDNF基线浓度高的抑郁症患者rTMS治疗效果更好,BDNF可以作为rTMS治疗抑郁症疗效的预测指标。

关键词: 重复经颅磁刺激, 抑郁症, 脑源性神经营养因子

Abstract: Objective To investigate the predictive effect of brain-derived neurotrophic factor (BDNF) on the efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of refractory depression. Methods Fifty-nine patients with refractory depression were randomly divided into treatment group (34 patients) and control group (25 patients). The treatment group received high frequency (10 Hz) rTMS for 2 weeks, while the control group was treated with sham rTMS stimulation. Hamilton Depression Scale-17 Item (HAMD-17) and Hamilton Anxiety Scale (HAMA) were used to evaluate clinical symptoms. Enzyme linked immunosorbent assay (ELISA) was used to examine the level of serum BDNF. The evaluation time point was baseline, 2 weeks after treatment, and 6 weeks follow-up. Results The scores of HAMD-17 and HAMA in the treatment and control groups decreased with the treatment time (P_time<0.05). There was no significant difference between the two groups (P _group>0.05). The response rate of the treatment group (70.59%) was higher than that of the control group (44%) after 2 weeks, with a statistically significant difference (P _group = 0.04). After treatment, the change of BDNF level in the treatment group was significantly more than that in the control group (P _group<0.05). There was a positive correlation between baseline BDNF level and efficacy (P<0.05). No serious adverse events occurred during the treatment. Conclusion rTMS was effective in the treatment of refractory depression. The treatment effect of rTMS was better in patients with high baseline level of serum BDNF than that with low baseline level. BDNF could be used as a predictor of the antidepressant effect of rTMS.

Key words: repetitive transcranial magnetic stimulation (rTMS), depression, brain-derived neurotrophic factor (BDNF)

中图分类号:

R749

孙丛丛, 吴涵, 周丹娜, 姜玮, 王雯, 杨春林, 马辛, 任艳萍. 脑源性神经营养因子对经颅磁刺激治疗难治性抑郁症的疗效预测作用[J]. 首都医科大学学报, 2022, 43(2): 227-232.

Sun Congcong, Wu Han, Zhou Danna, Jiang Wei, Wang Wen, Yang Chunlin, Ma Xin, Ren Yanping. Brain derived neurotrophic factor as the predictor of efficacy for repetitive transcranial magnetic stimulation in the treatment of refractory depression[J]. Journal of Capital Medical University, 2022, 43(2): 227-232.

参考文献

[1] Nemeroff C B. Prevalence and management of treatment-resistant depression[J]. J Clin Psychiatry, 2007, 68(Suppl 8): 17-25.
[2] Wang H Y, Crupi D, Liu J J, et al. Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte[J]. J Neurosci, 2011, 31(30): 11044-11054.
[3] Furtado C P, Hoy K E, Maller J J, et al. An investigation of medial temporal lobe changes and cognition following antidepressant response: a prospective rTMS study[J]. Brain Stimul, 2013, 6(3): 346-354.
[4] Molendijk M L, Bus B A A, Spinhoven P, et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment[J]. Mol Psychiatry, 2011, 16(11): 1088-1095.
[5] Haile C N, Murrough J W, Iosifescu D V, et al. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression[J]. Int J Neuropsychopharmacol, 2014, 17(2): 331-336.
[6] 袁娇, 徐乐平, 刘玉芝, 等. 重复经颅磁刺激对抑郁症患者血清脑源性神经营养因子水平影响的研究[J]. 中华行为医学与脑科学杂志, 2013, 22(3): 228-230.
[7] Su N, Zhang L, Fei F, et al. The brain-derived neurotrophic factor is associated with alcohol dependence-related depression and antidepressant response[J]. Brain Res, 2011, 1415: 119-126.
[8] Duclot F, Kabbaj M. Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants[J]. J Exp Biol, 2015, 218(Pt 1): 21-31.
[9] Yukimasa T, Yoshimura R, Tamagawa A, et al. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors[J]. Pharmacopsychiatry, 2006, 39(2): 52-59.
[10] Lang U E, Bajbouj M, Gallinat J, et al. Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation[J]. Psychopharmacology, 2006, 187(1): 56-59.
[11] Zhao X X, Li Y P, Tian Q, et al. Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1β and tumor necrosis factor-α in elderly patients with refractory depression[J]. J Int Med Res, 2019, 47(5): 1848-1855.
[12] American Psychiatric Association. Diagnostic and statistical manual for mental disorders-text revision[M]. 4th ed. Washington DC: American Psychiatric Association,2000.
[13] George M S, Post R M. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression[J]. Am J Psychiatry, 2011, 168(4): 356-364.
[14] Berlim M T, Van den Eynde F, Tovar-Perdomo S, et al. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials[J]. Psychol Med, 2014, 44(2): 225-239.
[15] Gedge L, Beaudoin A, Lazowski L, et al. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression[J]. Front Psychiatry,2012, 3: 12
[16] Zanardini R, Gazzoli A, Ventriglia M, et al. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients[J]. J Affect Disord, 2006, 91(1): 83-86.
[17] 赵国宁, 史振娟, 刘飞, 等. 重复经颅磁刺激联合艾司西酞普兰对抑郁症的临床疗效分析[J]. 临床研究, 2021, 29(9): 40-41.
[18] 钟健荣, 林本, 郑春玉, 等. 不同侧的背外侧前额叶rTMS治疗抑郁症的效果及对血清NSE、BDNF水平的影响[J]. 数理医药学杂志, 2021, 34(12): 1748-1750.
[19] 徐清, 程灶火, 刘晓伟, 等. 重复经颅磁刺激对慢性精神分裂症患者认知功能和血清脑源性神经营养因子水平的影响研究[J]. 中国全科医学, 2017, 20(25): 3171-3177.
[20] 马俊, 喻丽芝, 吴香云, 等. 重复经颅磁刺激对精神分裂症患者事件相关电位N400及血清脑源性神经营养因子水平的影响[J]. 临床精神医学杂志, 2019, 29(2): 87-90.
[21] 乔卉, 安书成, 徐畅. BDNF与抑郁症的研究现状及进展[J]. 生理科学进展, 2011, 42(3): 195-200.
[22] 丁苏彭, 蔡雨婷, 邵明, 等. 脑源性神经营养因子和抑郁症因果关系的两样本孟德尔随机化研究[J]. 徐州医科大学学报, 2021, 41(9): 640-645.
[23] 何嘉丽, 赖顺凯, 钟舒明, 等. 抑郁症认知功能损害与脑源性神经营养因子的基因遗传研究进展[J]. 中华精神科杂志, 2021, 54(1): 45-49.
[24] Lam R W, Chan P, Wilkins-Ho M, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis[J]. Can J Psychiatry, 2008, 53(9): 621-631.
[25] Schutter D J L G. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis[J]. Psychol Med, 2009, 39(1): 65-75.

脑源性神经营养因子对经颅磁刺激治疗难治性抑郁症的疗效预测作用

Brain derived neurotrophic factor as the predictor of efficacy for repetitive transcranial magnetic stimulation in the treatment of refractory depression

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨楠, 丁锚, 黄语悠, 房亚兰, 师文娟, 赵咏梅. 一氧化氮在大鼠短暂性局灶性脑缺血损伤中对神经生长因子和脑源性神经营养因子表达的影响[J]. 首都医科大学学报, 2020, 41(6): 908-913.
[2]	张颖彬, 莫林宏, 聂忆秋, 刘爱贤. 近红外脑功能成像在重复经颅磁刺激治疗脑卒中后轻度认知功能障碍的应用[J]. 首都医科大学学报, 2020, 41(6): 965-969.
[3]	王建平, 桂沛君, 谢瑛. 经颅直流电刺激治疗轻中度老年抑郁症的临床观察[J]. 首都医科大学学报, 2019, 40(6): 948-952.
[4]	李苗, 王群松, 袁国桢. 金匮肾气丸治疗肾虚肝郁型抑郁症的治疗效果及其对人血清神经生长因子的影响[J]. 首都医科大学学报, 2019, 40(2): 220-225.
[5]	时丹丹, 杨健, 张金钮, 王刚. 东莨菪碱对大鼠强迫游泳行为的影响及其作用靶点[J]. 首都医科大学学报, 2018, 39(5): 630-635.
[6]	唐利荣, 郑伟, 赵秀芹, 任艳萍, 向应强, 高越, 徐秋月, 马辛. 康复技能训练对抑郁症患者症状缓解和生活质量的作用[J]. 首都医科大学学报, 2018, 39(5): 636-640.
[7]	孙丛丛, 周丹娜, 宁芳平, 马良, 闫丽琼, 任艳萍, 马辛. 重复经颅磁刺激治疗难治性精神分裂症的增效作用研究[J]. 首都医科大学学报, 2018, 39(5): 641-645.
[8]	房亚兰, 黄语悠, 赵咏梅, 李锦程, 段云霞, 高利, 罗玉敏. 大黄酚对局灶性脑缺血再灌注小鼠脑组织p-CREB、BDNF和p-STAT3的影响[J]. 首都医科大学学报, 2018, 39(3): 360-365.
[9]	赵春松, 邹海强, 李晓波, 闫晓明, 关云谦, 张愚. CM-DiI标记人骨髓间充质干细胞并检测其移植后产生脑源性神经营养因子的实验研究[J]. 首都医科大学学报, 2017, 38(3): 423-430.
[10]	李苗, 袁国桢, 王群松, 周振和, 刘亮. 金匮肾气丸改善抑郁症病人疲劳感的临床研究[J]. 首都医科大学学报, 2017, 38(2): 197-201.
[11]	王群松, 季向东, 朱文娴, 于海燕. 针刺治疗对阴虚火旺型抑郁症的血清BDNF影响[J]. 首都医科大学学报, 2016, 37(2): 176-180.
[12]	谭赛, 雷小明, 王彦云, 潘菊华, 张颖, 黄世敬, 张永超, 郑军, 陈朝, 陈宇霞, 李多娇. 基于慢性缺血应激建立血管性抑郁症动物模型[J]. 首都医科大学学报, 2016, 37(2): 196-202.
[13]	屈赵, 张丽, 李林, 王奇, 尹琳琳. 不同剂量MOG_35-55对EAE小鼠p-JAK1、BDNF表达的影响[J]. 首都医科大学学报, 2014, 35(6): 725-729.
[14]	房萌, 任艳萍, 刘辉, 周方, 王刚. 重复经颅磁刺激联合帕罗西汀治疗重性抑郁障碍[J]. 首都医科大学学报, 2014, 35(2): 194-199.
[15]	尹梦雅, 贾竑晓, 朱虹, 刘嘉. 抑郁症患者的自我面孔识别研究[J]. 首都医科大学学报, 2013, 34(2): 207-210.